Exhibit 99.1

AGREEMENT OF JOINT FILING

The undersigned hereby agree that the Schedule 13G with respect to the ordinary shares, NIS 0.01 par value per share, of Vascular Biogenics Ltd. is, and any amendments thereto signed by each of the undersigned shall be, filed on behalf of each of us pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended.

Dated:  February 1, 2022	Regals Capital Management LP
	By: Regals Capital Holdings LLC, its general partner
	/s/ David M. Slager
	Name: David M. Slager
	Title: Managing Member
Dated:  February 1, 2022	Regals Fund LP
	By: Regals Fund GP LLC, its general partner
	/s/ David M. Slager
	Name: David M. Slager
	Title: Managing Member
Dated:  February 1, 2022	David M. Slager
	/s/ David M. Slager
	Name: David M. Slager